HEADER VIRAL PROTEIN 24-DEC-22 8HUT TITLE CRYSTAL STRUCTURE OF MERS MAIN PROTEASE IN COMPLEX WITH S217622 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORF1A; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_COMMON: MERS-COV; SOURCE 5 ORGANISM_TAXID: 1335626; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS VIRAL PROTEIN-INHIBITOR COMPLEX, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.LIN,J.ZHANG,J.LI REVDAT 2 07-FEB-24 8HUT 1 JRNL REVDAT 1 21-JUN-23 8HUT 0 JRNL AUTH C.LIN,H.JIANG,W.LI,P.ZENG,X.ZHOU,J.ZHANG,J.LI JRNL TITL STRUCTURAL BASIS FOR THE INHIBITION OF CORONAVIRAL MAIN JRNL TITL 2 PROTEASES BY ENSITRELVIR. JRNL REF STRUCTURE V. 31 1016 2023 JRNL REFN ISSN 0969-2126 JRNL PMID 37421945 JRNL DOI 10.1016/J.STR.2023.06.010 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 61.36 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.331 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 51444 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.908 REMARK 3 FREE R VALUE TEST SET COUNT : 2525 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 61.3600 - 5.1821 0.99 2996 165 0.1703 0.1798 REMARK 3 2 5.1821 - 4.1135 1.00 2918 133 0.1514 0.1746 REMARK 3 3 4.1135 - 3.5936 0.94 2724 125 0.1926 0.2559 REMARK 3 4 3.5936 - 3.2650 0.97 2759 122 0.2182 0.2479 REMARK 3 5 3.2650 - 3.0310 1.00 2832 156 0.2382 0.2496 REMARK 3 6 3.0310 - 2.8523 1.00 2813 147 0.2299 0.3269 REMARK 3 7 2.8523 - 2.7095 1.00 2835 139 0.2290 0.2867 REMARK 3 8 2.7095 - 2.5915 1.00 2775 154 0.2373 0.2376 REMARK 3 9 2.5915 - 2.4917 1.00 2790 172 0.2414 0.2681 REMARK 3 10 2.4917 - 2.4058 1.00 2789 160 0.2262 0.2736 REMARK 3 11 2.4058 - 2.3305 1.00 2800 160 0.2360 0.2886 REMARK 3 12 2.3305 - 2.2639 0.93 2603 134 0.2712 0.3690 REMARK 3 13 2.2639 - 2.2043 0.72 2017 109 0.4060 0.5056 REMARK 3 14 2.2043 - 2.1505 1.00 2788 129 0.2379 0.2509 REMARK 3 15 2.1505 - 2.1016 0.99 2807 120 0.2402 0.2924 REMARK 3 16 2.1016 - 2.0569 0.77 2142 106 0.2294 0.3160 REMARK 3 17 2.0569 - 2.0158 0.99 2767 134 0.2367 0.2744 REMARK 3 18 2.0158 - 1.9800 0.99 2764 160 0.2363 0.3182 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.273 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4622 REMARK 3 ANGLE : 0.850 6309 REMARK 3 CHIRALITY : 0.055 716 REMARK 3 PLANARITY : 0.006 792 REMARK 3 DIHEDRAL : 3.393 2647 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 10-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300034380. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51998 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 61.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 11.60 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.92600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM FORMATE, 0.1M BICINE PH8.5 REMARK 280 20% PEG5000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.10050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.33900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.64200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.33900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.10050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.64200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 2 REMARK 465 ALA B 46 REMARK 465 ASP B 47 REMARK 465 GLN B 48 REMARK 465 ILE B 72 REMARK 465 GLY B 73 REMARK 465 ALA B 74 REMARK 465 PRO B 75 REMARK 465 ALA B 76 REMARK 465 ASN B 77 REMARK 465 MET B 301 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 47 CG OD1 OD2 REMARK 470 GLN A 48 CG CD OE1 NE2 REMARK 470 LEU A 49 CG CD1 CD2 REMARK 470 ASN A 77 CG OD1 ND2 REMARK 470 GLU A 156 CG CD OE1 OE2 REMARK 470 GLN A 241 CG CD OE1 NE2 REMARK 470 GLN A 249 CG CD OE1 NE2 REMARK 470 GLN A 277 CG CD OE1 NE2 REMARK 470 MET A 286 CG SD CE REMARK 470 LEU B 49 CG CD1 CD2 REMARK 470 ASP B 51 CG OD1 OD2 REMARK 470 GLN B 69 CG CD OE1 NE2 REMARK 470 ARG B 79 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 156 CG CD OE1 OE2 REMARK 470 LYS B 191 CG CD CE NZ REMARK 470 GLN B 277 CG CD OE1 NE2 REMARK 470 LYS B 279 CG CD CE NZ REMARK 470 GLN B 280 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -124.52 50.61 REMARK 500 GLN A 48 4.06 89.80 REMARK 500 ASP A 51 70.55 -152.47 REMARK 500 PRO A 75 -178.11 -63.70 REMARK 500 ALA A 220 21.38 -143.19 REMARK 500 GLN A 277 -122.08 51.97 REMARK 500 LEU B 27 -167.85 -162.43 REMARK 500 ASP B 33 -121.74 51.92 REMARK 500 ASP B 51 74.23 -153.60 REMARK 500 LYS B 140 75.54 -101.71 REMARK 500 ASN B 172 -169.10 -65.53 REMARK 500 ALA B 220 18.33 -144.12 REMARK 500 GLN B 277 -114.88 54.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 75 ALA A 76 -144.27 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HUT A 2 301 UNP T2B9I2 T2B9I2_MERS 3249 3548 DBREF 8HUT B 2 301 UNP T2B9I2 T2B9I2_MERS 3249 3548 SEQADV 8HUT ALA A 148 UNP T2B9I2 CYS 3395 CONFLICT SEQADV 8HUT ALA B 148 UNP T2B9I2 CYS 3395 CONFLICT SEQRES 1 A 300 GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL GLU SEQRES 2 A 300 ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR LEU SEQRES 3 A 300 ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO ARG SEQRES 4 A 300 HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO ASN SEQRES 5 A 300 TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER PHE SEQRES 6 A 300 SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU ARG SEQRES 7 A 300 VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS LEU SEQRES 8 A 300 THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR THR SEQRES 9 A 300 PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL LEU SEQRES 10 A 300 ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR VAL SEQRES 11 A 300 VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE LEU SEQRES 12 A 300 CYS GLY SER ALA GLY SER VAL GLY TYR THR LYS GLU GLY SEQRES 13 A 300 SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU LEU SEQRES 14 A 300 ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY THR SEQRES 15 A 300 MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN VAL SEQRES 16 A 300 GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL ALA SEQRES 17 A 300 TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP PHE SEQRES 18 A 300 VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN GLU SEQRES 19 A 300 TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY THR SEQRES 20 A 300 GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL ALA SEQRES 21 A 300 ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR THR SEQRES 22 A 300 GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET LEU SEQRES 23 A 300 GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN ILE SEQRES 24 A 300 MET SEQRES 1 B 300 GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL GLU SEQRES 2 B 300 ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR LEU SEQRES 3 B 300 ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO ARG SEQRES 4 B 300 HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO ASN SEQRES 5 B 300 TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER PHE SEQRES 6 B 300 SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU ARG SEQRES 7 B 300 VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS LEU SEQRES 8 B 300 THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR THR SEQRES 9 B 300 PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL LEU SEQRES 10 B 300 ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR VAL SEQRES 11 B 300 VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE LEU SEQRES 12 B 300 CYS GLY SER ALA GLY SER VAL GLY TYR THR LYS GLU GLY SEQRES 13 B 300 SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU LEU SEQRES 14 B 300 ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY THR SEQRES 15 B 300 MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN VAL SEQRES 16 B 300 GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL ALA SEQRES 17 B 300 TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP PHE SEQRES 18 B 300 VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN GLU SEQRES 19 B 300 TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY THR SEQRES 20 B 300 GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL ALA SEQRES 21 B 300 ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR THR SEQRES 22 B 300 GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET LEU SEQRES 23 B 300 GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN ILE SEQRES 24 B 300 MET HET 7YY A 401 37 HET 7YY B 401 37 HETNAM 7YY 6-[(6-CHLORANYL-2-METHYL-INDAZOL-5-YL)AMINO]-3-[(1- HETNAM 2 7YY METHYL-1,2,4-TRIAZOL-3-YL)METHYL]-1-[[2,4,5- HETNAM 3 7YY TRIS(FLUORANYL)PHENYL]METHYL]-1,3,5-TRIAZINE-2,4-DIONE FORMUL 3 7YY 2(C22 H17 CL F3 N9 O2) FORMUL 5 HOH *130(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 MET A 61 1 9 HELIX 4 AA4 THR A 62 HIS A 64 5 3 HELIX 5 AA5 MET A 184 PHE A 188 5 5 HELIX 6 AA6 CYS A 203 ASN A 217 1 15 HELIX 7 AA7 SER A 229 ASN A 240 1 12 HELIX 8 AA8 THR A 248 GLY A 259 1 12 HELIX 9 AA9 ALA A 261 TYR A 273 1 13 HELIX 10 AB1 THR A 292 MET A 301 1 10 HELIX 11 AB2 SER B 10 ALA B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 ASN B 53 MET B 61 1 9 HELIX 14 AB5 MET B 184 PHE B 188 5 5 HELIX 15 AB6 CYS B 203 ASN B 217 1 15 HELIX 16 AB7 SER B 229 ASN B 240 1 12 HELIX 17 AB8 THR B 248 GLY B 259 1 12 HELIX 18 AB9 ALA B 261 GLY B 275 1 15 HELIX 19 AC1 THR B 292 ILE B 300 1 9 SHEET 1 AA1 6 PHE A 66 GLN A 69 0 SHEET 2 AA1 6 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 3 AA1 6 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 4 AA1 6 THR A 35 PRO A 39 -1 O TRP A 37 N LEU A 30 SHEET 5 AA1 6 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 6 AA1 6 VAL A 80 GLN A 86 -1 N GLN A 86 O LEU A 89 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N GLY A 152 O TYR A 164 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N SER A 116 O TYR A 153 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 THR A 174 SER A 178 -1 O THR A 174 N LEU A 170 SHEET 1 AA4 6 PHE B 66 GLN B 69 0 SHEET 2 AA4 6 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 3 AA4 6 MET B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 4 AA4 6 THR B 35 PRO B 39 -1 O TRP B 37 N LEU B 30 SHEET 5 AA4 6 LEU B 89 VAL B 94 -1 O LEU B 90 N CYS B 38 SHEET 6 AA4 6 VAL B 80 GLN B 86 -1 N VAL B 81 O THR B 93 SHEET 1 AA5 5 TYR B 104 THR B 105 0 SHEET 2 AA5 5 VAL B 159 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA5 5 VAL B 151 GLU B 156 -1 N GLY B 152 O TYR B 164 SHEET 4 AA5 5 ALA B 114 TYR B 121 -1 N SER B 116 O TYR B 153 SHEET 5 AA5 5 ARG B 124 VAL B 132 -1 O THR B 126 N ALA B 119 SHEET 1 AA6 3 TYR B 104 THR B 105 0 SHEET 2 AA6 3 VAL B 159 GLU B 169 1 O PHE B 162 N THR B 105 SHEET 3 AA6 3 HIS B 175 SER B 178 -1 O SER B 178 N MET B 165 CRYST1 80.201 95.284 98.678 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012469 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010495 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010134 0.00000